Thursday, 1 February 2018

Contraceptives Market to be Evaluated at US$ 37,242.7 Million by the End of 2025

According to Transparency Market Research (TMR) the global contraceptives market is anticipated to grow at a steady CAGR of 6.1% within the forecast period. This figure was evaluated to be worth US$ 22,050 mn in year 2016. This worth is expected to be around US$ 37,242.7 mn by year 2025. On the basis of the key product type, preventative gadgets holds importance with the fragment holding around 53.2% market share in year 2016. Healthcare medical store dominates among the major conveyance channels by through several great elements. Based on geography, North America accounts for interesting development prospects as compared with other major regions for contraceptives. Be that as it may, Asia Pacific is prepared to project the key development pace over the conjecture time frame.


Within the key elements supporting the contraceptives market is the increasing awareness battles that engender contraceptives to act as an innovative technique to anticipate unintended or unplanned pregnancies that is contributing to their expanded reception within youthful and juvenile masses in both developing and developed nations. The movement that are by and large attempted by NGOs and government offices are run by celebrities that is favoring the use of contraceptives within the young crowd who possess the outlook to copy popular people.

In developing areas, mostly within the urban people, sexual desires and current instruction are significant elements for the increased usage of contraceptives. Rise in number of females in the nuclear family setups and worksapce are prompting expanding usage of contraceptives to abort the pregnancies. Moreover, couples are looking for the innovation for prevention to be received and directed with respect to family plans that are convenient for them.

Moreover, the growing number of cases suffering from sexually transmitted infections is likewise encouraging the usage of contraceptives in global market. This is because of the fact that contraceptives, such as, topical prophylactic fix and condoms are successful to avoid or prevent sexually transmitted diseases, such as AIDS times of diseased sexual contacts with different accomplices.


Further, the awareness crusades likewise offer master direction about selection of best strategy for contraception relying upon singular need. Overall health of women, frequency of sexual action, age, will to have kids in future, and family history are a portion of the components that gynecologists investigate before informing the strategy with respect to contraception. Finally, improvement of novel prophylactic items by encouraging reigning players is additionally working in favor for the contraceptives market.

The worldwide contraceptives market is foreseen to experience exceptional competition with the emergence of a huge number of companies that work globally. Nevertheless, Bayer AG sustained as the victorious business in year 2016 ascribed to its several solid worldwide presence and item portfolio. This has supported other key players to create effective and affordable contraception products in coming years.

Some other major firms in the contraceptives market are Cipla Inc., Mankind Pharma, Mithra Pharmaceuticals, Janssen Pharmaceutical Company, Teva Pharmaceutical Industries Ltd., Allergan plc, Merck Co. Inc., Pfizer Inc., HLL Lifecare Limited, Reckitt Benckiser plc among the rest of them. Moreover, Pharmaceutical organizations ViiV Healthcare — a worldwide expert HIV organization framed in 2009 through an extraordinary association amongst GSK and Pfizer — and Belgium-based Janssen, have additionally grabbed the nanoparticles and are utilizing them to form a warehouse infusion into the muscle, which means one infusion could give HIV prescriptions to up to 3 months. Though the pediatric and oral plans are still years from making it on to the market, the main injections are in stage II and III clinical trials and may be accessible.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Skin Replacement Therapy Market Growth Opportunities and Forecast up to 2024

Ever since its advent by John F. Burke, synthetic skin or artificial skin has proved to be a boon for victims of burns and other skin diseases. Synthetic skin protects a patient from infection and dehydration and is readily accepted by the immune system, and thus, the global skin replacement market is witnessing a growth. Synthetic skin can be easily sterilized at room temperature and is excellent for combating chronic or acute skin wounds and infections. The skin is the largest organ in the human body and serves the body in various was, but protection is its main function.
The skin protects the various organs and tissues inside the human body form disease carrying bacteria, toxins, cold, heat, and similar other external threats. Thus, it is important to ensure the good health of the skin and any loss of the skin due to severe burns or trauma of any kind can pose a threat and expose the inside organs and tissues to potential dangers. This can also lead to impairment or inability of an organ to perform its functions. All these factors are slated to drive the demand for skin replacement. The large scale production of artificial skin can lead to instant availability for grafting and this will make it economical for burn patients to opt for artificial skin. Extensive research and development, growing importance for aesthetically appealing skin, and increasing disposable income are some of the factors boosting the global skin replacement market.
Skin replacement therapy helps treat severe skin burns or chronic skin wounds. Skin cancer, eczema, and psoriasis are some of the skin diseases that can be painful and can compromise the quality of life led by a person. Thus arises a need for skin replacement therapy. The skin is the largest external organ of the human body and is one of the organs most vulnerable to injuries and damages. Since the skin protects the musculoskeletal system, the organs, and also helps maintain the temperature of the body, it becomes very essential for the skin to function properly. Moreover, the skin also regulates the level of fluids in the body. Thus, any skin disease or injury needs to be treated immediately as the lack of it can impact the person’s ability to lead a normal life.
The global skin replacement therapy market is segmented on the basis of material used, end user, and geography. On the basis of material used, the market is segmented into spider silk and collagen. By geography, the global skin replacement therapy market is segmented into Europe, Asia Pacific, North America, and the Rest of the World.
The report is a professional and detailed study on the current state of the market, taking into consideration historical figures. The future projections of the global skin replacement therapy market is forecast for the period from 2016 to 2024. The report offers accurate data and compiles fruitful information with the help of primary and secondary research methods, enabling enterprises and interested individuals to have a competitive edge above the rest.
An increasing prevalence of skin diseases and injuries among people and subsequently the rising consciousness among them to have healthy and beautiful skin are driving the global skin replacement therapy market. The continual expansion of product range available in the market enables consumers to access specific skin replacement therapies in line with the skin condition they are suffering from. The ability of consumers to spend on these therapies or products has motivated manufacturers to develop and introduce newer products, thus helping the global skin replacement therapy market to grow.
The global skin replacement therapy market is challenged by the availability of low-cost substitutes. The lack of clinical support is another probable factor that may threaten the growth of the global skin replacement therapy market. However, bio-engineered skin replacements will open new opportunities for growth in the market. These replacements are capable of closely mimicking almost all functions of the natural skin and are thus expected to be in huge demand.
By geography, North America contributes a significant portion to the skin replacement therapy market revenue. The demand for skin replacement therapies in Asia Pacific is expected to rise in the coming years as many countries in the region are offering attractive medical tourism packages.
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Ultrasonic Electrosurgical Devices Market Growth Opportunities and Forecast Up to 2025

Surgical energy devices are used during open as well as minimally invasive surgeries for performing procedures such as tissue cutting, dissection, and coagulation. Thermal energy generated by surgical energy devices is employed to perform these procedures. Conventional energy devices use electric energy or lasers to generate heat that performs tissue cutting, dissection, and coagulation. Developments in minimally invasive surgical procedures such as laparoscopy have led to development of ultrasonic electrosurgical devices. These devices use mechanical energy of vibrations, which generates heat. These vibrations break hydrogen bonds in a protein structure, which results in generation of extracellular and intracellular heat. This heat facilitates cutting and coagulation. Ultrasonic electrosurgical devices do not require grounding plates, which eliminates the need to pass the current through the patient’s body. This enables use of these devices in patients with metal implants such as joint implants, cardiac implants, and others.


Ultrasonic electrosurgical devices produce less heat, which avoids the charring effect. This makes them a preferred choice of surgeons in performing open and minimally invasive surgeries. These devices are being widely used in gynecology surgeries, bariatric surgeries, urology surgeries, cardiovascular surgeries, and general surgeries. Increasing prevalence of chronic diseases across the globe and rising access to health care facilities have led to surge in the number of surgeries worldwide. Rising demand for patient safety during surgeries is likely to increase the adoption for ultrasonic electrosurgical devices in the near future. Ultrasonic electrosurgical devices in the past were used for sealing of vessels measuring 3– 5 mm in diameter, while present-day devices have the ability to seal vessels measuring 7 mm in diameter. Moreover, there is no need to change the device to perform functions such as cutting, dissection, coagulation, and co-aptation. These factors are likely to drive the global ultrasonic electrosurgical devices market during the forecast period. However, ultrasonic electrosurgical consumables such as shears and blades are expensive and they have less durability compared to conventional electrosurgical devices. This factor is anticipated to restrain the market from 2017 to 2025.

The global ultrasonic electrosurgical devices market can be segmented based on product, application, end-user, and region. In terms of product, the market can be divided into generators and consumables. The consumables segment comprises handheld devices such as shears, scalpels, and blades. Most of the consumables available in the market are disposable in nature or have a limited usage cycle. This factor is likely to contribute to the leading share held by the segment. Based on application, the market can be segmented into cardiology, gynecology, general surgery, urology, bariatric surgery, and others. The cardiology segment is likely to witness prominent growth during the forecast period. The general surgery segment is estimated to account for a leading share of the market from 2017 to 2025, owing to the large number of surgeries being performed in this segment. Based on end-user, the market can be segmented into hospitals, ambulatory surgical centers, and others. The ambulatory surgical centers segment is likely to register the maximum growth rate during the forecast period, owing to increasing number of these centers and rising number of minimally invasive surgeries.


Geographically, the global ultrasonic electrosurgical devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is estimated to constitute a leading share of the global market during the forecast period, owing to high adoption of technologies and high health care expenditure in the region. Europe is anticipated to account for a significant share of the global market between 2017 and 2025. Increase in the number of surgeries performed in this region is projected to fuel the market in Europe during the forecast period. The market in Asia Pacific is projected to witness high growth during the forecast period, owing to increasing health care expenditure in the region.

Major players operating in the global ultrasonic electrosurgical devices market are Ethicon Endo-Surgery (a part of Johnson & Johnson), Olympus Corporation, Medtronic, BOWA-electronic GmbH & Co. KG, Söring GmbH, Advanced Instrumentations, Reach Surgical, and ITALIA MEDICA SRL.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Cardioplegia Cannulae Market Value Chain Analysis and Forecast Up to 2025

Cardioplegia cannulae increases the myocardial protection during a cardiac surgery. Research studies have indicated that, in case of patients undergoing cardiac arrest, especially on-pump cardiac surgeries, combined use of retrograde and ante-grade cardioplegia is the best treatment approach for increasing myocardial protection. Cardioplegia cannulae are used in various types of surgeries such as coronary sinus perfusion and minimally invasive aortic root surgeries. In these procedures, a standard cannula is difficult to insert, as it involves a risk of myocardial abrasion. Introduction of technologically advanced products such as cannula with phospholipid coating enhancing biocompatibility, are factors driving the growth of the market in 2016.


Adequate reimbursement policies for cardiovascular surgeries and related products, rising preference for minimally invasive techniques, increasing per capita health care expenditure in emerging countries, and improving healthcare infrastructure are some of the factors likely to drive the global cardioplegia cannulae market during the forecast period. However, high cost of equipment and requirement for skilled physicians to perform surgeries are some of the factors restraining the global cardioplegia cannulae market. Several emerging players are coming up with cost-effective products with innovative technologies. This factor is likely to augment the global cardioplegia cannulae market during the forecast period.

The global cardioplegia cannulae market can be segmented based on product type, usage type, type of material used, end-user, and region. Based on product type, the market has been bifurcated into ante-grade cannulae and retrograde cannulae. The ante-grade cardioplegia refers to delivery of solutions via coronary arteries, whereas the retrograde cardioplegia refers to delivery of solutions through coronary veins. The retrograde cardioplegia cannulae segment has been further divided into self-inflating balloons and manually inflating balloons. These balloons are either smooth or textured. In terms of usage type, the global cardioplegia cannulae market has been classified into re-usable cardioplegia cannulae and single-use/disposable cardioplegia cannulae. Based on type of material used, the market has been categorized into polyurethane, silicone, polyvinyl chloride (PVC), biocompatible material, and others. Based on end-user, the market has been divided into hospitals, cardiac clinics, and ambulatory surgical centers.


Based on geography, the global cardioplegia cannulae market has been segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is likely to dominate the global cardioplegia cannulae market, in terms of revenue, during the forecast period. This is attributable to high average selling price of the product, high adoption of advanced minimally invasive techniques by end-users, and rise in the incidence of cardiovascular abnormalities caused by sedentary lifestyle. However, the market in Asia Pacific is projected to expand at a significant CAGR during the forecast period, due to the large number of patients with cardiovascular diseases, increase in the market penetration by local manufacturers, and low entry barriers for established market players in the region to enhance their geographical presence.

Superior technological innovations such as suture flanges and luer locking needles are likely to increase the rate of adoption of cardioplegia cannulae during the forecast period. Rising number of mergers and collaborations by major market players to penetrate this relatively untapped market with high growth potential is a growing trend. Development of skilled surgeons and establishment of proper infrastructure in developing countries are likely to offer growth opportunities to the global cardioplegia cannulae market during the forecast period.

Key players operating in the global cardioplegia cannulae market are Edwards Lifesciences Corporation, Medtronic, (Sorin Group) LivaNova PLC, (Terumo Cardiovascular Systems Corporation) TERUMO CORPORATION, ANDOCOR N.V., Braile Biomédica, Surge Cardiovascular, (MAQUET Holding B.V. & Co. KG.) Getinge Group, and Vitalcor, Inc.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Surgical Retractors Market Key Trends and Opportunity Analysis 2025

Surgical retractors are handheld surgical instruments used by a surgeon during surgical procedure. Surgical retractors are used manually or by through a robot method. Surgical retractors are also categorized into handheld and self-retaining. These instruments are available in different shapes, sizes, and styles for use in different types of surgery. Surgical retractors are also referred as surgical detractors. Surgical retractor is a simple steel tool with a curvy or angled blade at one end and a handle to hold it comfortably. A surgeon needs to choose an appropriate retractor according to the need of the surgery. For example, hand-cranked surgical retractor is used for rib surgery, and a thoracic retractor is employed for thoracic surgeries. Both reusable and disposable surgical retractors are available in the market. Surgical retractors are used to separate the edges of surgical incision or wound and to hold back tissue or organ.


Rise in surgical procedures globally have increased demand for surgical instruments. This is projected to boost the growth of the surgical retractors market during the forecast period. According to the World Health Organization (WHO), nearly 4,511 surgical procedures were performed per 100,000 people in 2012. Rise in prevalence and incidence of chronic diseases has increased the number of surgical procedures globally, which is a primary factor driving the surgical retractors market. According to the Centers for Disease Control and Prevention (CDC), seven of the top 10 causes of death in 2014 were chronic diseases. Two of these chronic diseases heart disease and cancer accounted for nearly 46% of all deaths. Moreover, rise in the geriatric population has increased the number of reconstructive and minimally invasive surgical procedures. This in turn is expected to boost the growth of the global surgical retractors market. Stringent regulations by the FDA for the approval of surgical equipment is anticipated to hamper the growth of the market.

The global surgical retractors market can be segmented based on product type, application, end-user, and region. In terms of product type, the market can be categorized into finger retractor, nerve retractor, orthopedic retractor, rectal retractor, thoracic retractor, ribbon retractor, self-retaining retractor, and others. Based on application, the global surgical retractors market can be divided into endoscopy, surgery, dental, urology, and others. The surgery segment can be classified into orthopedic, nervous system, digestive system, ophthalmology, and others. In terms of end-user, the market can be segmented into hospitals, clinics, ambulatory surgical centers, and others.


Geographically, the global surgical retractors market can be segmented into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounts for the largest share of the global surgical retractors market due to the adoption of new technologies and favorable reimbursement scenario for surgical procedures in the region. Europe accounts for the second largest market share in terms of revenue owing to rise in the number of plastic surgeons and favorable regulatory framework. The market in Asia Pacific is expected to expand at a high CAGR during the forecast period due to rise in medical tourism in countries such as India, China, and other countries in Asia Pacific. Latin America and Middle East & Africa are expected to be prospective markets in the near future due to increase in health care expenditure and improvement in health care infrastructure.

Key players operating in the global surgical retractors market are Becton Dickinson and Company, Sklar Surgical Instruments, Teleflex Incorporated, BR Surgical, CONMED Corporation, Medtronic, Olympus Corporation, and CooperSurgical, Inc.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Single-Use Bioreactors Market to Rake in Over US$ 1.5 Billion Revenues by the End of 2026

Transparency Market Research (TMR), which recently prepared a report on the global market for single-use bioreactors, finds that it is primed for good growth over the course of the forecast period between 2017 and 2026. It states that by registering a CAGR of 13.5%, the market will likely reach a value of US$1.55 bn by the end of 2026.


The different types of single-use bioreactors available in the market are media bags, filtration assemblies, and single use bioreactor systems. The single use bioreactor systems of them are expected to expand at a healthy clip in the next couple of years. Media bags form another attractive product segment and together with single use bioreactor systems, is expected to generate over half the revenue in the market.

North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa are some of the prominent regions in the global market for single-use bioreactors. Europe, of them, leads the market because of the presence of some of the well-known pharmaceutical companies in the region. Supportive policies meant to boost efforts by biopharmaceutical companies to come up with new therapies in biologics is also benefitting the market in the region along with the rising application of single-use bioreactors in cell culture-based manufacturing.

Commercial considerations are mostly driving the use of single-use bioreactors. Manufacturers are keen to ensure that their products bring about cost savings in biopharmaceutical companies. “While single-use bioreactor bags are generating pathways that can manufacture protein-based drugs securely, the compounds or materials have a tendency to leak on account of the extrusion process that makes the bag films thin. Fixing of such risks by stabilizing the materials has spelt new opportunities for savvy companies trying to increase their sales,” explains the TMR analyst who prepared the report.


Depending upon end user, the biopharmaceutical companies are predicted to generate maximum demand. Currently, players are focusing on designing new generation single-use bioreactors, keeping in mind the final drug product required by end users.

Recent developments in single-use bioreactors by manufacturers are focused on improving mixing, bringing down complexity, and avoiding leakage, and other integrity issues. Apart from that, bettering cell-culture processes are also driving rising adoption of single-use bioreactors.
Single-use bioreactors, which are ideally suited for manufacturing biopharmaceutical products because of their high-performance, have become highly evolved these days thanks to constant efforts by players to develop products. They are seen working on improving designs, sensor systems, film technology, and stirring mechanism of single-use bioreactors. In doing so, they are factoring in the specific requirements of their clients vis-à-vis gene and cell therapies and for continued bioprocessing.

Some of the prominent participants in the global single-use bioreactors market are Stedim Biotech, Sartorius Merck Millipore, Thermo Fisher Scientific, GE Healthcare, Celltainer Biotech, Danaher, Applikon Biotechnology, Parker Hannifin, Cesco Bioengineering, PBS Biotech, Cellexus, Distek, Pierre Guerin, Eppendorf, and Solida Biotech.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:

Membrane Separation Systems Market to Touch a Revenue Valuation of US$ 61,801.9 Million by 2025

As per estimates of a report by Transparency Market Research (TMR), the global membrane separation systems market will clock a CAGR of 9.3% for the forecast period from 2017 to 2025. Expanding at this rate, the market’s valuation of US$28,134.4 mn in 2016 will become US$61,801.9 mn by the end of 2025.

The microfiltration segment, among the key technology segments, held the leading share in the global membrane separation systems market in 2016. By application, the environmental segment holds the leading share among other segments in the membrane separation systems market. Europe held the commanding share vis-à-vis revenue in the global membrane separation systems market among other key regions in 2016.


Amongst several driving factors, a significant part of the demand for membrane separation systems originates from municipal corporations. At present, measures for water reuse and wastewater treatment to save wastage of the essential commodity is the consideration of environmental agencies. This has boosted the uptake of membrane separation technologies, which in turn is stoking demand for membrane separation systems.

In particular, emerging economies that are underway rapid industrialization and facing population explosion in water-stressed areas are expected to augment the growth of this market in the upcoming years.

Membrane separation technology has emerged as the most important separation technology over the last couple of years. This is because membrane separation technology is free of chemicals, consumes less energy, and operates in an organized manner, which conventional separation techniques lack. Due to the distinct offerings of membrane separation technology, it is increasingly being used for different processes in water management, wastewater and process water treatment, food and beverage, life sciences, and pharmaceutical industries. The technology is also used for separation processes in chemical, petrochemical, and manufacturing industries.


Apart from this, several governments and metropolitan planners are awakening to the impact in the event of a shortage of water which is an everyday essentiality. This is pushing the need for innovations for water treatment, thereby paving way for the growth of the worldwide market for membrane separation systems.

However, on the downside, high establishment and operational costs, insufficient infrastructure, and availability of other water cleaning and treatment procedures are posing a challenge to the growth of membrane separation systems market.

Amidst a fragmented vendor landscape in the global membrane separation systems market, large players that operate globally have been observed to hold supremacy in the overall market, as per one of the current reports by Transparency Market Research (TMR). In a typical scenario in this market, small scale vendors operate in regional markets serving a few end-use industries, whereas market leaders such as The Dow Chemical Company and Koch Membrane Systems Inc. not only operate globally but have serve a number of end-use industries. The topnotch companies are also upping spends on research and development to introduce innovative systems.

Pall Corporation, Sartorius AG, 3M, Amazon Filters, Advantec MFS Inc., GE Healthcare, Merck Millipore, Novasep, and TriSep Corporation (Microdyn-Nadir US, Inc.) are to name some other prominent companies in the global membrane separation systems market.


About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com
Posted by at No comments:
Labels:
Subscribe to: Posts (Atom)